You have been invited to assemble a task force to design a medication assistance program. You need to submit a proposal, regarding whom you would invite, to the CEO. Consider the perspectives of prescribers, discharge planners, financial navigators, patients, suppliers, bookkeepers, and subsidizers. If you were to seek the input of 5-7 stakeholders, who would you invite to the planning table, and why? Consider the need for a group facilitator. Whom would that person be, and why?

Title: Designing a Medication Assistance Program: Stakeholder Perspectives and the Role of a Group Facilitator


The design and implementation of a successful medication assistance program require the collaboration and input of various stakeholders. These stakeholders bring unique perspectives and expertise that are vital in developing a comprehensive and effective program. In this proposal, we will discuss the essential stakeholders to invite to the planning table and the importance of a group facilitator in ensuring a productive and inclusive process.

Stakeholders and their Perspectives:

1. Prescribers:
Prescribers play a critical role in medication assistance programs as they are responsible for prescribing medications. Their expertise in understanding the medication needs of patients and the potential challenges faced during the prescribing process is invaluable. Inviting prescribers will enable us to incorporate their insights into the program design and ensure its alignment with medical best practices.

2. Discharge Planners:
Discharge planners are typically involved in the transition of patients from hospital settings to home or other care facilities. Their inclusion in the planning process is essential as they possess knowledge of patients’ conditions, medication requirements, and post-hospitalization needs. Their insights can guide the development of a program that effectively supports patients during the critical transition period.

3. Financial Navigators:
Financial navigators or patient advocates are instrumental in understanding and navigating the complex financial aspects of healthcare. Their involvement will help ensure that the medication assistance program addresses the financial barriers patients face in accessing medications. Financial navigators can also provide insights into potential sources of financial assistance and reimbursement options for patients.

4. Patients:
The inclusion of patient representatives is vital to ensure that the medication assistance program meets the needs and preferences of the target population. Patients can provide valuable insights into their experiences, challenges, and expectations regarding medication access and affordability. Their perspectives will facilitate patient-centered program design and help identify potential obstacles and areas for improvement.

5. Suppliers:
Suppliers, such as pharmaceutical manufacturers and distributors, have a direct impact on medication availability and affordability. Their involvement in the planning process is crucial for understanding supply chain dynamics, potential bottlenecks, and considerations related to sourcing medications. Collaborating with suppliers will enable us to align the program design with the realities of the medication market.

6. Bookkeepers:
Bookkeepers or financial personnel are essential stakeholders, as they have expertise in managing budgetary considerations, cost-effectiveness, and financial sustainability. Their insights will be instrumental in designing a program that optimizes resources and balances costs while ensuring the program’s long-term viability.

7. Subsidizers:
Subsidizers, including government agencies and charitable organizations, play a critical role in funding and supporting medication assistance programs. Their perspectives are crucial for understanding eligibility criteria, funding opportunities, and compliance requirements. Engaging subsidizers from the early stages of program design will help ensure alignment with their expectations and requirements.

Role of a Group Facilitator:

To ensure a productive planning process and effective communication among stakeholders, appointing a group facilitator is essential. The facilitator should be an individual skilled in process facilitation, knowledgeable about medication assistance programs, and neutral in their approach. The facilitator acts as a neutral mediator, guiding discussions, maintaining focus, and ensuring a fair and inclusive decision-making process.

The group facilitator’s responsibilities include:

1. Establishing an inclusive and respectful environment where all stakeholders feel heard and valued.
2. Guiding discussions towards consensus-building and ensuring all perspectives are considered.
3. Managing conflicts that may arise during the planning process and finding common ground.
4. Ensuring the planning process adheres to a timeline and achieves the desired outcomes.
5. Documenting discussions, decisions, and action plans to facilitate transparency and accountability.

While the specific choice of a group facilitator may vary based on organizational preferences and availability of qualified candidates, individuals with expertise in healthcare management or program development and experience in facilitating complex initiatives are ideally suited for this role.


In conclusion, the success of a medication assistance program depends on the input and collaboration of various stakeholders representing prescribers, discharge planners, financial navigators, patients, suppliers, bookkeepers, and subsidizers. Each stakeholder brings unique perspectives and expertise that contribute to the program’s effectiveness and sustainability. Additionally, appointing a skilled group facilitator is crucial to ensure a productive planning process, effective communication, and inclusive decision-making. Together, these stakeholders and the chosen facilitator will work towards designing a medication assistance program that addresses patient needs, enhances medication access, and optimizes financial resources.